Week of January 31st 2022 | Vol. 11, Issue 5
Events Hosted or Attended by Bourne Partners
March 21-24, 2022 - New York City, NY

October 2022- Charlotte, NC
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
Insight Into Healthcare Related Industries
Representative Current Retained Sell-Side And Partnering Opportunities
Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business

Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
A Sampling of Industry Headlines From Last Week
In one of the more apt examples of bringing medtech into the home and meeting patients on their terms, the developer of a smart toilet seat has raised $30 million to pursue an FDA clearance.
What if the information you need to gauge your risk of a heart attack within the next year could be found in your eyes? Researchers led by the University of Leeds believe that to be true, and they’ve trained an artificial intelligence program to spot the warning signs.
Less than two years after scoring its first FDA clearance, Akili Interactive is betting big on its digital therapeutic technology. The Massachusetts-based company has signed a reverse-merger deal with Social Capital Suvretta Holdings Corp. I to make its own public debut.
After receiving a European approval for its laparoscopic surgery robot at the end of 2020, Distalmotion has raised $90 million to help take its system to the U.S.

The Medicine Maker features Banks Bourne, Founder and CEO of Tanner Pharma Group, as he discusses how companies can reimagine and strengthen their supply chains when presented with unique challenges.

Over the last 3 months our friends at MAP International have distributed 16,000+ units of Tanner and PAI donated products to support children in 7 countries around the world. Learn more about this collaboration here.